RAbMono™ (Rabbit Monoclonals)

RAbMono™, Rabbit monoclonals designed and developed at Zeta are uniquely produced and target-validated for IHC on FFPE tissue sections. Zeta’s RAbMono™ (Rabbit Monoclonal) antibodies stand out because of their superior specificity, low background, and high affinity.

In contrast to typical mouse monoclonal technology, Zeta has achieved a unique and effective rabbit monoclonal production platform based on our unmatched expertise in the field.  Generally, Rabbit Monoclonals are characterized by 10 to 100 times higher affinity than Mouse Monoclonals.  The rabbit’s immune system is better equipped to generate a response to smaller antigens that are not detected in mice.

As a result, Rabbit Monoclonals are becoming increasingly popular in the immunohistochemical detection of tumor markers in humans.